Physician profile
Todd D Mccall
NPI 1508054297
$16,253.49
in general payments reported to CMS, 2019-2025
9 companies · $3,401 in 2025
The $3,401 reported for 2025 was more than what 76% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $806 · 2020: $338 · 2021: $551 · 2022: $4,734 · 2023: $2,348 · 2024: $4,076 · 2025: $3,401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,181 · Food and Beverage: $2,644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,181.19 |
| Food and Beverage | $2,643.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,656.20 | 2021-2025 | Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System, Intellis Adaptivestim |
| Globus Medical, INC. | $3,672.37 | 2024-2025 | Excelsiusgps Robotic Navigation System, Xlif, Creo 5.5 |
| Cerapedics INC. | $2,148.65 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic USA, INC. | $609.95 | 2019-2020 | |
| Aesculap Implant Systems, LLC | $491.98 | 2019-2022 | |
| Si-Bone, INC. | $378.86 | 2019-2024 | |
| Nevro Corp. | $179.66 | 2019-2022 | |
| Icotec Medical INC. | $66.20 | 2023 | Icotec Blackarmor Spine System |
| Boston Scientific Corporation | $49.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Mccall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.